(Bloomberg) -- France is trying to block the European Union from conducting talks on pending trade deals until after its presidential election in April, when incumbent Emmanuel Macron faces a crowded field of candidates.
Discussions are ongoing between Paris and the European Commission, the EU’s executive arm that plays the central role in trade negotiations, according to people familiar with the matter. A French diplomat confirmed Paris will oppose trade talks.
Talks with New Zealand and Chile are among the negotiations the French government is seeking to freeze, said one of the people, who asked not to be identified because the discussions are private.
Free-trade agreements can be controversial in France and in the past have been weaponized during election campaigns. Macron is leading the run-up to the first round of elections in April and will likely face a far-right candidate in a runoff.
A call to a commission spokesperson for comment wasn’t immediately returned.
Trade negotiations in the EU are conducted by the commission and no single government has the power to veto talks once they have begun. Once an agreement is reached, national governments then need to approve the deal for it to enter into force.
The EU is currently negotiating a trade deal with New Zealand and working to update aspects of its association agreement with Chile.
Discussions with Chile are particularly sensitive. When Macron and Chilean President Sebastian Pinera met in Paris last month, the two leaders issued a statement saying they talked about “how to accelerate the new association agreement between France, the EU and Chile that is about to be reached.”
Paris already asked to delay talks with Australia after it lost a massive submarine deal to the U.S. and the U.K.
©2021 Bloomberg L.P.
BNN Bloomberg Picks
Elizabeth Holmes deflects, regrets and laments over 6 days
Amazon says it resolved network device issue that caused outage
Nestle will trim stake in L’Oreal to 20% with share sale
How to deal with shopping anxiety this holiday season
Glaxo-Medicago COVID shot effective against Delta in trial
Apple gets another street-high target on virtual reality boost